Skip to main content
Advertisement
Advertisement

CLRB

CLRB logo

Cellectar Biosciences INC NEW

1.45
USD
Sponsored
+0.05
+3.57%
Oct 09, 15:59 UTC -4
Closed
exchange

After-Market

1.45

0.00
+0.21%

CLRB Earnings Reports

Positive Surprise Ratio

CLRB beat 21 of 41 last estimates.

51%

Next Report

Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.56
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
-60.28%

Cellectar Biosciences INC NEW earnings per share and revenue

On Aug 13, 2026, CLRB reported earnings of -0.56 USD per share (EPS) for Q2 26, missing the estimate of -0.49 USD, resulting in a -15.62% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.62% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.56 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
Oct 06, 2026 For Q1 27
Estimate
-$0.07
Actual
$0.08
Surprise
+212.04%
logo
Tilray Brands, Inc. Common Stock
Report Date
Oct 08, 2026 For Q1 27
Estimate
-$0.19
Actual
-$0.32
Surprise
-64.27%
FAQ
For Q2 2026, Cellectar Biosciences INC NEW reported EPS of -$0.56, missing estimates by -15.62%, and revenue of $0.00, 0% as expectations.
The stock price moved down -4.62%, changed from $2.60 before the earnings release to $2.48 the day after.
The next earning report is scheduled for Nov 11, 2026.
Based on 5 analysts, Cellectar Biosciences INC NEW is expected to report EPS of -$0.56 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement